Dinesh Khanna, MD, MSc
Frederick G L Huetwell Professor of Rheumatology
Professor of Internal Medicine and Program Director
Internal Medicine
Medical School
Email:
[email protected]
Phone:
Available to mentor
Dinesh Khanna, MD, MSc
Professor
Manage Your Profile
Qualifications
-
MSUCLA, 1237 Murphy Hall x 951419, Los Angeles, CA, 90095, United States
2002 - 2004
-
MB BSUniversity College of Medical Sciences, Dilshad Garden, Delhi, 110 095, India
1990 - 1996
Center Memberships
-
Center MemberInstitute for Healthcare Policy and Innovation
Recent Publications
-
Ikari Y, Lu C, Rosek A, Cai A, Khanna N, St Clair J, Webber A, Foster C, Chen YC, Ali RA, Khanna D, Fox DA, Tsou PS. Arthritis Research and Therapy, 2026 Dec 1; 28 (1):Journal ArticleSoluble CD13 in systemic sclerosis: clinical observations and transcriptomic insights from peripheral blood
DOI:10.1186/s13075-025-03723-4 PMID: 41520101 -
McLaughlin VV, Solum D, Lachant D, Ataya A, Barberà JA, Meyer GB, Chang SA, Channick R, Church C, Feenstra J, Gaine S, Giannakoulas G, Jerjes-Sanchez C, Khanna D, Kim NH, Oudiz R, Preston IR, Sood N, Torres F, Vachiery JL, Pulido T, Cella D, Deng C, Escudero M, Lacasse V, Peterson L, Benza R, Humbert M. Lancet, 2026 Aug 8; 408 (10554): 521 - 531.Journal ArticleRalinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study
DOI:10.1016/S0140-6736(26)01011-1 PMID: 42520828 -
Del Galdo F, Allanore Y, Distler O, Hoffmann-Vold AM, Johnson S, Khanna D, Ong VH, Renzoni EA, Volkmann ER, Denton CP. Nat Rev Rheumatol, 2026 Aug 4;Journal ArticleNavigating evidence-based recommendations for the management of systemic sclerosis.
DOI:10.1038/s41584-026-01416-z PMID: 42552374 -
Distler O, Khanna D, Spiera R, Gudjonsson JE, Julia V, Wagner N, Rossini M, Zhu J, Piketty C. Journal of Scleroderma and Related Disorders, 2026 Jul 11; 11 (2): e000027Journal ArticlePhase II randomised, double-blind, placebo-controlled, dose-ranging study of nemolizumab with an extension period in adult patients with systemic sclerosis: THESSALIA study design and rationale
DOI:10.1136/jsrd-2026-000027 -
Agarwal A, Hassan D, Huang S, Castelino FV, Assassi S, Domsic RT, Frech TM, Gordon JK, Hant FN, Hinchcliff ME, Shah AA, Shanmugam VK, Steen VD, Khanna D, Bernstein EJ. Semin Arthritis Rheum, 2026 Jun 26; 80: 153037Journal ArticleAutoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosis.
DOI:10.1016/j.semarthrit.2026.153037 PMID: PMC13336313 -
Wells M, Smith T, Domsic RT, Anilkumar A, Frech TM, Herrick AL, Hummers LK, Shah AA, Denton CP, Khanna D, Barratt SL, Pauling JD. Rheumatology (Oxford), 2026 Jun 3; 65 (6):Journal ArticleThe clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.
DOI:10.1093/rheumatology/keag267 PMID: 42172612 -
Benfaremo D, Khanna D, Campochiaro C, Cottin V, Luppi F, Matucci-Cerinic M, Moroncini G, Allanore Y. Arthritis Rheumatol, 2026 Jun 1;Journal ArticleExpert Perspectives: Defining and managing progressive pulmonary fibrosis in systemic sclerosis.
DOI:10.1002/art.70237 PMID: 42223210 -
Ayla AY, Bernstein EJ, Zhang M, Vanburen JM, Castelino FV, Chung L, Evnin L, Frech TM, Gordon JK, Hant FN, Hummers LK, Khanna D, Lakin KS, Lebiedz-Odrobina D, Luo Y, Makol A, Mayes M, Mcmahan ZH, Molitor JA, Moore DF, Richardson C, Sandorfi N, Shah AA, Shah A, Shanmugam VK, Skaug B, Steen VD, Volkmann ER, Zahn C, Zheng WJ, Assassi S. Journal of Rheumatology, 2026 May 1; 53 (5): 519 - 528.Journal ArticleAssociation of Type III and Type VI Collagen Neoepitopes With Disease Severity in Systemic Sclerosis
DOI:10.3899/jrheum.2025-0532 PMID: 41241390
Featured News & Stories
Health Lab
A scleroderma clinical trial brings a better quality of life for one participant
The CAR-T treatment has been used in cancer patients for years. Now the approach is being used for those with severe scleroderma to teach the body to fight the autoimmune disorder.
